Lepu Biopharma Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 35.42 | -100% | -208.4 | -100% |
| P/S |
|
25.92 | 7.59 | 241.61% |
|
|
| P/BV |
|
5.98 | 3.68 | 62.19% |
|
|
| P/FCF |
|
-31.39 | 55.3 | -156.76% |
|
|
| Ev/Ebitda |
|
-15.37 | 2.91 | -628.56% |
|
|
| Ev/S |
|
27.21 | 23.72 | 14.76% |
|
|
| Ev/FCF |
|
-19.09 | 63.78 | -129.94% |
|
|
| E/P |
|
-0.0022 | 0.0326 | -106.74% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-3830.77 | -11.9 | 32087.19% | -3838.64 | -0.2049% |
| ROE |
|
-2.2 | 5.19 | -142.46% |
|
|
| ROA |
|
-0.8055 | 3.47 | -123.22% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-9.79 | -11.49 | -14.77% |
|
|
| ROCE |
|
0 | 6.04 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.16 | 0.7755 | -249.23% | -1.16 | 0% |
| Nеt Debt/Ebitda |
|
-0.4484 | 0.0127 | -3622.26% |
|
|
| Debt/Ratio |
|
0.29 | 0.1229 | 136.09% |
|
|
| Debt/Equity |
|
0.6643 | 0.802 | -17.16% |
|
|
| Debt/Net Income |
|
-34.52 | 1.76 | -2063.83% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 2.43 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.21 | -100% | ||
| DSI |
|
0 | 0.563 | -100% |
|
|
| Average dividend growth |
|
0 | 3.2 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.82 | -100% |
|
|
| Average percentage for payments |
|
0 | 23.96 | -100% |
|
|
| Difference from average difference in sector |
|
-2.43 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1180.68 | 28.69 | 4015.3% | ||
| Growth impulse Ebitda in 5 years |
|
63.23 | -40.52 | -256.05% | ||
| Growth impulse Net Income in 5 years |
|
-95.06 | 94.84 | -200.23% | ||
| Growth impulse FCF in 5 years |
|
-41.86 | 91.41 | -145.79% | ||
| Growth impulse EPS in 5 years |
|
-95.01 | -118.14 | -19.58% |
IP Score
3.18/10
